Skip to main content
Clinical Trials/JPRN-UMIN000010357
JPRN-UMIN000010357
Completed
未知

Effect of the use of dialyzer having excellent performance for removal of cytokines on clinical observation in maintenance HD patients - Tokai Cytokine Removal Study

Tokai Cytokine Removal Study Group0 sites20 target enrollmentApril 1, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypercytokinemia in maintenance hemodialysis patients
Sponsor
Tokai Cytokine Removal Study Group
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tokai Cytokine Removal Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who are receiving renal replacement therapies other than hemodialysis, continuous ambulatory peritoneal dialysis and hemodiafiltration, excluding hemodialysis. 2\) Patients who are enrolled to other clinical study. 3\) Cancer bearing patients or a patient who received radical surgery for cancer in less than 3 years. 4\) Patients who have a history of cardiovascular diseases (myocardial infarction, stroke) in less than 6 months. 5\) Patients who have peripheral arterial disease classified in more than Fontaine classification class II. 6\) Patients who have uncontrolled diabetes despite standard treatments. 7\) Patients who are considered to have acute inflammation with CRP of higher than 2 mg/dL. 8\) Patients with uncontrolled anemia (Hb \<8\.5 g/dL) despite ESA treatment. 9\) Patients who are pregnant or intends to become pregnant within one year. 10\) Patients who are judged as the inadequate subject of this study by the doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials